Project Grant 2629959
- This Project Grant, awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports fundamental research into the epigenetic control of tissue regeneration across multiple species and developmental stages. The research project, funded at $435,875 and performed by Vanderbilt University's Sponsored Programs Administration in Nashville, Tennessee, will generate scientific knowledge regarding how gene...
- The National Institute of General Medical Sciences (NIGMS) awarded the Regents of the University of Michigan a $400,881 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) on February 26, 2026, with a completion date of December 31, 2030. The award funds research titled "Uncovering Morphogenetic Modularity with Data Science," which investigates the fundamental principles governing tissue formation and development in early embryos. The primary...
- This four-year, $708,333 National Science Foundation project grant funds research at Georgia Tech Research Corporation to develop genetic and microfluidic technologies to direct the differentiation of human induced pluripotent stem cell-derived retinal organoids. Specifically, the researchers will apply genome-wide methods leveraging both cell differentiation and biomechanical properties to screen for pathways that regulate retinogenesis. Systems biology approaches will identify master...
- This is a $1,200,000 Project Grant awarded by the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) to the Texas A&M Engineering Experiment Station (Tees) for the period of September 1, 2024 to August 31, 2028. The grant supports research to understand how common biological signaling pathways like the Bone Morphogenetic Protein (BMP) pathway can be both widely used and flexible to meet the needs of different tissues across the animal kingdom. The project involves...
- This Project Grant, awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), funds fundamental research into the molecular and systems-level mechanisms that enable developing organs to achieve consistent size and shape despite cellular variability and environmental fluctuations. Cornell University's laboratory will conduct a five-year research initiative (August 1, 2025 – May 31, 2030) with total federal...
- This Project Grant from the National Science Foundation, under the Biological Sciences program (CFDA 47.074), provides $240,000 to fund research investigating gene regulatory network evolution across 13 species of roundworms. The fellowship award supports a postdoctoral researcher from June 1, 2023 to May 31, 2026. The researcher will use single-cell sequencing to build molecular atlases of embryonic development for each roundworm species, comparing gene expression patterns across tissues and...
- Federal Project Grant Award Summary The Mount Desert Island Biological Laboratory (MDIBL) received a $432,543 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025, through July 31, 2030. The award funds the Emerging Leaders in Regenerative Biology and Development (REBILD) program, designed to address the critical workforce shortage in regenerative and developmental biology...
- Grant Award Summary The University of California, San Diego received a $654,038 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded July 25, 2025, with a completion date of April 30, 2030. The grant supports fundamental research addressing how single cells transform into fully formed, functional organisms through a biophysical framework titled "Flows, Fates and Forces: A...
- Grant Award Summary The National Science Foundation's Division of Molecular and Cellular Biosciences awarded Dartmouth College a $690,177 Project Grant under the Biological Sciences program (CFDA 47.074) effective May 1, 2026, through April 30, 2030. This collaborative research initiative will deliver fundamental scientific findings on zygotic genome activation (ZGA)—the developmental transition from maternal to embryo-produced RNA—through integrated live imaging, genetic analysis, and genomic...
- This Project Grant awarded by the National Science Foundation (NSF) Biological Sciences Program (CFDA 47.074) will support research to investigate the biochemical mechanisms that regulate receptor tyrosine kinase (RTK) proteins and their impact on the development of brain circuits controlling social and emotional behaviors. The $600,000 award, spanning 2025-2027, will be conducted by Children's Hospital Los Angeles, a prominent pediatric academic medical center and research institution. The...
CONFERENCE: 2027 DEVELOPMENTAL BIOLOGY GORDON RESEARCH CONFERENCE AND SEMINAR -THE JOINT 2027 GORDON RESEARCH CONFERENCE (GRC) AND TRAINEE-LED GORDON RESEARCH SEMINAR (GRS) IN DEVELOPMENTAL BIOLOGY WILL BRING TOGETHER LEADING SCIENTISTS FROM AROUND THE WORLD TO EXPLORE HOW LIVING ORGANISMS GROW, DEVELOP, REPAIR, AND REGENERATE CELL TYPES AND TISSUES. FOR OVER 40 YEARS THE BIANNUAL GRC IN DEVELOPMENTAL BIOLOGY HAS BEEN THE LEADING CONFERENCE IN THE FIELD, ORGANIZED BY ELECTED MEMBERS OF THE RESEARCH COMMUNITY, AND WITH SUPPORT OF THE PROFESSIONAL GRC STAFF. TO BE HELD JANUARY 16?22, 2027, THIS LONGSTANDING MEETING PROVIDES A UNIQUE ENVIRONMENT FOR SHARING THE LATEST DISCOVERIES, FOSTERING COLLABORATIONS, AND TRAINING THE NEXT GENERATION OF SCIENTIFIC LEADERS. SUPPORT FROM THE NSF WILL ENABLE PARTICIPATION BY U.S.-BASED GRADUATE STUDENTS, POSTDOCTORAL RESEARCHERS, AND EARLY-CAREER INVESTIGATORS WHO MIGHT OTHERWISE BE UNABLE TO ATTEND. THE GRC/GRS IN DEVELOPMENTAL BIOLOGY UNIQUELY EMPHASIZES DISCUSSION OF EMERGING, UNPUBLISHED RESEARCH IN A COLLABORATIVE SETTING THAT ENCOURAGES NEW IDEAS AND LONG-TERM PARTNERSHIPS. THE TRAINEE-LED GRS OFFERS EARLY-CAREER RESEARCHERS A DEDICATED FORUM TO PRESENT THEIR WORK, RECEIVE FEEDBACK, DEVELOP PROFESSIONAL NETWORKS, AND ENGAGE DIRECTLY WITH ESTABLISHED LEADERS IN THE FIELD. TOGETHER, THE GRS AND GRC STRENGTHEN THE DEVELOPMENTAL BIOLOGY COMMUNITY BY PROMOTING BROAD PARTICIPATION, INTERDISCIPLINARY COLLABORATION, AND SUSTAINED MENTORING ACROSS CAREER STAGES. ADVANCES PRESENTED AT THE 2027 MEETING WILL DEEPEN OUR UNDERSTANDING OF THE FUNDAMENTAL PRINCIPLES THAT SHAPE LIVING ORGANISMS, WHILE INFORMING NEW APPROACHES IN REGENERATIVE MEDICINE, BIOTECHNOLOGY, AND THE TREATMENT OF HUMAN DISEASE. BY SUPPORTING SCIENTIFIC EXCHANGE AND WORKFORCE DEVELOPMENT, THE CONFERENCE WILL ENHANCE U.S. LEADERSHIP IN BIOMEDICAL RESEARCH AND HELP PREPARE THE NEXT GENERATION OF INVESTIGATORS TO ADDRESS MAJOR BIOMEDICAL AND SOCIETAL CHALLENGES. THE 2027 GRS/GRC IN DEVELOPMENTAL BIOLOGY, THEMED ORGANIZING PRINCIPLES OF GROWTH, FORM, AND REGENERATION DRIVING TRANSFORMATIVE APPLICATIONS, WILL CONVENE RESEARCHERS ACROSS DEVELOPMENTAL BIOLOGY, REGENERATIVE BIOLOGY, QUANTITATIVE BIOLOGY, BIOPHYSICS, BIOENGINEERING, AND COMPUTATIONAL BIOLOGY TO IDENTIFY UNIFYING PRINCIPLES GOVERNING GROWTH, MORPHOGENESIS, AND REGENERATION. SCIENTIFIC SESSIONS WILL SPAN DISCOVERIES FROM ESTABLISHED AND EMERGING MODEL SYSTEMS, QUANTITATIVE AND PHYSICAL APPROACHES TO DEVELOPMENTAL MECHANISMS, AND INNOVATIVE TECHNOLOGIES (INCLUDING ADVANCED -OMICS, IMAGING, COMPUTATION, MATHEMATICAL MODELING, AND ARTIFICIAL INTELLIGENCE) THAT ARE TRANSFORMING STUDIES OF DEVELOPMENT, DISEASE, AND BIOENGINEERING. THE MEETING'S EMPHASIS ON UNPUBLISHED RESEARCH, EXTENDED DISCUSSION, AND TRAINEE PARTICIPATION WILL ACCELERATE INTERDISCIPLINARY COLLABORATION, FOSTER NEW SCIENTIFIC FRAMEWORKS, AND SUPPORT THE PROFESSIONAL DEVELOPMENT OF EARLY-CAREER INVESTIGATORS WHILE ADVANCING FUNDAMENTAL BIOLOGICAL KNOWLEDGE WITH BROAD BIOMEDICAL APPLICATIONS. THIS PROJECT ADVANCES NSF?S PRIORITIES IN BIOTECHNOLOGY AND ARTIFICIAL INTELLIGENCE. THIS AWARD REFLECTS NSF'S STATUTORY MISSION AND HAS BEEN DEEMED WORTHY OF SUPPORT THROUGH EVALUATION USING THE FOUNDATION'S INTELLECTUAL MERIT AND BROADER IMPACTS REVIEW CRITERIA.- SUBAWARDS ARE NOT PLANNED FOR THIS AWARD.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $19.0k | 7/9/26 |